BONE MORPHOGENETIC PROTEIN MARKET Challenges and Opportunities

One of the key challenges for the global bone morphogenetic protein market is the high costs associated with bone morphogenetic protein therapies. These therapies are among the most expensive in regenerative medicine and orthopedic treatments. The high costs can limit the adoption of these therapies among consumers and healthcare providers. The costs of bone morphogenetic protein-based therapies are attributed to expensive manufacturing and production process using biopharmaceutical techniques.

Market Opportunity - Growing demand for minimally invasive surgical procedures

The demand for minimally invasive surgical procedures is growing significantly across the globe. This growing demand presents a key opportunity for the bone morphogenetic protein market. Bone morphogenetic proteins are increasingly being used during minimally invasive orthopedic procedures like spinal fusion surgeries and fracture treatments. These minimally invasive techniques offer advantages like lesser trauma, fewer incisions, shorter hospital stay, and quicker recovery time compared to traditional open surgeries.